These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 23887079)
1. Embryonic transcription factors CDX2 and Oct4 are overexpressed in neuroendocrine tumors of the ileum: a pilot study. Heverhagen AE; Geis C; Fendrich V; Ramaswamy A; Montalbano R; Di Fazio P; Bartsch DK; Ocker M; Quint K Eur Surg Res; 2013; 51(1-2):14-20. PubMed ID: 23887079 [TBL] [Abstract][Full Text] [Related]
2. Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex. Geis C; Fendrich V; Rexin P; Di Fazio P; Bartsch DK; Ocker M; Quint K; Heverhagen AE J Surg Res; 2015 Apr; 194(2):388-393. PubMed ID: 25439321 [TBL] [Abstract][Full Text] [Related]
3. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Witek ME; Nielsen K; Walters R; Hyslop T; Palazzo J; Schulz S; Waldman SA Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8549-56. PubMed ID: 16361536 [TBL] [Abstract][Full Text] [Related]
4. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704 [TBL] [Abstract][Full Text] [Related]
5. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Hermann G; Konukiewitz B; Schmitt A; Perren A; Klöppel G Virchows Arch; 2011 Aug; 459(2):147-54. PubMed ID: 21739268 [TBL] [Abstract][Full Text] [Related]
6. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Ralston A; Cox BJ; Nishioka N; Sasaki H; Chea E; Rugg-Gunn P; Guo G; Robson P; Draper JS; Rossant J Development; 2010 Feb; 137(3):395-403. PubMed ID: 20081188 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383 [TBL] [Abstract][Full Text] [Related]
8. Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Fendrich V; Waldmann J; Esni F; Ramaswamy A; Mullendore M; Buchholz M; Maitra A; Feldmann G Endocr Relat Cancer; 2007 Sep; 14(3):865-74. PubMed ID: 17914115 [TBL] [Abstract][Full Text] [Related]
9. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Erickson LA; Papouchado B; Dimashkieh H; Zhang S; Nakamura N; Lloyd RV Endocr Pathol; 2004; 15(3):247-52. PubMed ID: 15640551 [TBL] [Abstract][Full Text] [Related]
10. Cdx2 acts downstream of cell polarization to cell-autonomously promote trophectoderm fate in the early mouse embryo. Ralston A; Rossant J Dev Biol; 2008 Jan; 313(2):614-29. PubMed ID: 18067887 [TBL] [Abstract][Full Text] [Related]
11. CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer. Olsen J; Eiholm S; Kirkeby LT; Espersen ML; Jess P; Gögenür I; Olsen J; Troelsen JT Exp Mol Pathol; 2016 Feb; 100(1):59-66. PubMed ID: 26551082 [TBL] [Abstract][Full Text] [Related]
12. Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases. Zimmermann N; Lazar-Karsten P; Keck T; Billmann F; Schmid S; Brabant G; Thorns C Anticancer Res; 2016 Mar; 36(3):921-4. PubMed ID: 26976979 [TBL] [Abstract][Full Text] [Related]
13. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808 [TBL] [Abstract][Full Text] [Related]
14. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2. Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108 [TBL] [Abstract][Full Text] [Related]
15. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917 [TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin. Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217 [TBL] [Abstract][Full Text] [Related]
18. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
19. Expression and functional role of Cdx2 in intestinal metaplasia of cystitis glandularis. Lin ME; Huang D; Deng BH; Lv YS; Rong L; Yao YS J Urol; 2013 Sep; 190(3):1083-9. PubMed ID: 23545100 [TBL] [Abstract][Full Text] [Related]
20. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]